Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, 외. (December 2007). “Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths”. 《Lancet》 370 (9602): 1829–1839. doi:10.1016/S0140-6736(07)61778-4. PMID18061058. S2CID54293528.
Taylor FC, Huffman M, Ebrahim S (December 2013). “Statin therapy for primary prevention of cardiovascular disease”. 《JAMA》 310 (22): 2451–2452. doi:10.1001/jama.2013.281348. PMID24276813.
Fulcher J, O'Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, 외. (April 2015). “Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials”. 《Lancet》 385 (9976): 1397–1405. doi:10.1016/s0140-6736(14)61368-4. hdl:2123/14127. PMID25579834. S2CID35330627.
Cangemi, Roberto; Romiti, Giulio Francesco; Campolongo, Giuseppe; Ruscio, Eleonora; Sciomer, Susanna; Gianfrilli, Daniele; Raparelli, Valeria (March 2017). “Gender related differences in treatment and response to statins in primary and secondary cardiovascular prevention: The never-ending debate”. 《Pharmacological Research》 117: 148–155. doi:10.1016/j.phrs.2016.12.027. PMID28012963. S2CID32861954.
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, 외. (June 2019). “2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol”. 《Journal of the American College of Cardiology》 73 (24): e285–e350. doi:10.1016/j.jacc.2018.11.003. PMID30423393.
Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, García FA, 외. (November 2016). “Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement”. 《JAMA》 316 (19): 1997–2007. doi:10.1001/jama.2016.15450. PMID27838723. S2CID205075217.
Kostis WJ, Cheng JQ, Dobrzynski JM, Cabrera J, Kostis JB (February 2012). “Meta-analysis of statin effects in women versus men”. 《Journal of the American College of Cardiology》 59 (6): 572–582. doi:10.1016/j.jacc.2011.09.067. PMID22300691.
Petretta M, Costanzo P, Perrone-Filardi P, Chiariello M (January 2010). “Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis”. 《International Journal of Cardiology》 138 (1): 25–31. doi:10.1016/j.ijcard.2008.08.001. PMID18793814.
Ray KK, Seshasai SR, Erqou S, Sever P, Jukema JW, Ford I, 외. (June 2010). “Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants”. 《Archives of Internal Medicine》 170 (12): 1024–1031. doi:10.1001/archinternmed.2010.182. PMID20585067.
Bukkapatnam RN, Gabler NB, Lewis WR (2010). “Statins for primary prevention of cardiovascular mortality in women: a systematic review and meta-analysis”. 《Preventive Cardiology》 13 (2): 84–90. doi:10.1111/j.1751-7141.2009.00059.x. PMID20377811.
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, 외. (June 2014). “2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines”. 《Circulation》 129 (25 Suppl 2): S1–45. doi:10.1161/01.cir.0000437738.63853.7a. PMID24222016.
de Waal BA, Buise MP, van Zundert AA (January 2015). “Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery: a review”. 《British Journal of Anaesthesia》 114 (1): 44–52. doi:10.1093/bja/aeu295. PMID25186819.
Antoniou GA, Hajibandeh S, Hajibandeh S, Vallabhaneni SR, Brennan JA, Torella F (February 2015). “Meta-analysis of the effects of statins on perioperative outcomes in vascular and endovascular surgery”. 《Journal of Vascular Surgery》 61 (2): 519–532.e1. doi:10.1016/j.jvs.2014.10.021. PMID25498191.
Li YH, Ueng KC, Jeng JS, Charng MJ, Lin TH, Chien KL, 외. (April 2017). “2017 Taiwan lipid guidelines for high risk patients”. 《Journal of the Formosan Medical Association = Taiwan Yi Zhi》 116 (4): 217–248. doi:10.1016/j.jfma.2016.11.013. PMID28242176.
Repas TB, Tanner JR (February 2014). “Preventing early cardiovascular death in patients with familial hypercholesterolemia”. 《The Journal of the American Osteopathic Association》 114 (2): 99–108. doi:10.7556/jaoa.2014.023. PMID24481802.
Ramasamy I (February 2016). “Update on the molecular biology of dyslipidemias”. 《Clinica Chimica Acta; International Journal of Clinical Chemistry》 454: 143–185. doi:10.1016/j.cca.2015.10.033. PMID26546829.
Lamaida N, Capuano E, Pinto L, Capuano E, Capuano R, Capuano V (September 2013). “The safety of statins in children”. 《Acta Paediatrica》 102 (9): 857–862. doi:10.1111/apa.12280. PMID23631461. S2CID22846175.
Liu YH, Liu Y, Duan CY, Tan N, Chen JY, Zhou YL, 외. (March 2015). “Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials”. 《Journal of Cardiovascular Pharmacology and Therapeutics》 20 (2): 181–192. doi:10.1177/1074248414549462. PMID25193735. S2CID28251228.
Brault M, Ray J, Gomez YH, Mantzoros CS, Daskalopoulou SS (June 2014). “Statin treatment and new-onset diabetes: a review of proposed mechanisms”. 《Metabolism》 63 (6): 735–745. doi:10.1016/j.metabol.2014.02.014. PMID24641882.
Mancini GB, Baker S, Bergeron J, Fitchett D, Frohlich J, Genest J, 외. (2011). “Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference”. 《The Canadian Journal of Cardiology》 27 (5): 635–662. doi:10.1016/j.cjca.2011.05.007. PMID21963058.
Finegold JA, Manisty CH, Goldacre B, Barron AJ, Francis DP (April 2014). “What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice”. 《European Journal of Preventive Cardiology》 21 (4): 464–474. doi:10.1177/2047487314525531. PMID24623264. S2CID21064267.
World Health Organization (2019). 《World Health Organization model list of essential medicines: 21st list 2019》. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
Fulcher J, O'Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, 외. (April 2015). “Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials”. 《Lancet》 385 (9976): 1397–1405. doi:10.1016/s0140-6736(14)61368-4. hdl:2123/14127. PMID25579834. S2CID35330627.
National Collaborating Centre for Primary Care (2010). 《NICE clinical guideline 67: Lipid modification》(PDF). London: National Institute for Health and Clinical Excellence. 38쪽. 10 October 2010에 원본 문서(PDF)에서 보존된 문서.
Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, 외. (December 2007). “Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths”. 《Lancet》 370 (9602): 1829–1839. doi:10.1016/S0140-6736(07)61778-4. PMID18061058. S2CID54293528.
Taylor FC, Huffman M, Ebrahim S (December 2013). “Statin therapy for primary prevention of cardiovascular disease”. 《JAMA》 310 (22): 2451–2452. doi:10.1001/jama.2013.281348. PMID24276813.
Fulcher J, O'Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, 외. (April 2015). “Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials”. 《Lancet》 385 (9976): 1397–1405. doi:10.1016/s0140-6736(14)61368-4. hdl:2123/14127. PMID25579834. S2CID35330627.
Cangemi, Roberto; Romiti, Giulio Francesco; Campolongo, Giuseppe; Ruscio, Eleonora; Sciomer, Susanna; Gianfrilli, Daniele; Raparelli, Valeria (March 2017). “Gender related differences in treatment and response to statins in primary and secondary cardiovascular prevention: The never-ending debate”. 《Pharmacological Research》 117: 148–155. doi:10.1016/j.phrs.2016.12.027. PMID28012963. S2CID32861954.
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, 외. (June 2019). “2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol”. 《Journal of the American College of Cardiology》 73 (24): e285–e350. doi:10.1016/j.jacc.2018.11.003. PMID30423393.
Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, García FA, 외. (November 2016). “Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement”. 《JAMA》 316 (19): 1997–2007. doi:10.1001/jama.2016.15450. PMID27838723. S2CID205075217.
Kostis WJ, Cheng JQ, Dobrzynski JM, Cabrera J, Kostis JB (February 2012). “Meta-analysis of statin effects in women versus men”. 《Journal of the American College of Cardiology》 59 (6): 572–582. doi:10.1016/j.jacc.2011.09.067. PMID22300691.
Petretta M, Costanzo P, Perrone-Filardi P, Chiariello M (January 2010). “Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis”. 《International Journal of Cardiology》 138 (1): 25–31. doi:10.1016/j.ijcard.2008.08.001. PMID18793814.
Ray KK, Seshasai SR, Erqou S, Sever P, Jukema JW, Ford I, 외. (June 2010). “Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants”. 《Archives of Internal Medicine》 170 (12): 1024–1031. doi:10.1001/archinternmed.2010.182. PMID20585067.
Bukkapatnam RN, Gabler NB, Lewis WR (2010). “Statins for primary prevention of cardiovascular mortality in women: a systematic review and meta-analysis”. 《Preventive Cardiology》 13 (2): 84–90. doi:10.1111/j.1751-7141.2009.00059.x. PMID20377811.
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, 외. (June 2014). “2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines”. 《Circulation》 129 (25 Suppl 2): S1–45. doi:10.1161/01.cir.0000437738.63853.7a. PMID24222016.
de Waal BA, Buise MP, van Zundert AA (January 2015). “Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery: a review”. 《British Journal of Anaesthesia》 114 (1): 44–52. doi:10.1093/bja/aeu295. PMID25186819.
Antoniou GA, Hajibandeh S, Hajibandeh S, Vallabhaneni SR, Brennan JA, Torella F (February 2015). “Meta-analysis of the effects of statins on perioperative outcomes in vascular and endovascular surgery”. 《Journal of Vascular Surgery》 61 (2): 519–532.e1. doi:10.1016/j.jvs.2014.10.021. PMID25498191.
Li YH, Ueng KC, Jeng JS, Charng MJ, Lin TH, Chien KL, 외. (April 2017). “2017 Taiwan lipid guidelines for high risk patients”. 《Journal of the Formosan Medical Association = Taiwan Yi Zhi》 116 (4): 217–248. doi:10.1016/j.jfma.2016.11.013. PMID28242176.
Repas TB, Tanner JR (February 2014). “Preventing early cardiovascular death in patients with familial hypercholesterolemia”. 《The Journal of the American Osteopathic Association》 114 (2): 99–108. doi:10.7556/jaoa.2014.023. PMID24481802.
Ramasamy I (February 2016). “Update on the molecular biology of dyslipidemias”. 《Clinica Chimica Acta; International Journal of Clinical Chemistry》 454: 143–185. doi:10.1016/j.cca.2015.10.033. PMID26546829.
Lamaida N, Capuano E, Pinto L, Capuano E, Capuano R, Capuano V (September 2013). “The safety of statins in children”. 《Acta Paediatrica》 102 (9): 857–862. doi:10.1111/apa.12280. PMID23631461. S2CID22846175.
Liu YH, Liu Y, Duan CY, Tan N, Chen JY, Zhou YL, 외. (March 2015). “Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials”. 《Journal of Cardiovascular Pharmacology and Therapeutics》 20 (2): 181–192. doi:10.1177/1074248414549462. PMID25193735. S2CID28251228.
Brault M, Ray J, Gomez YH, Mantzoros CS, Daskalopoulou SS (June 2014). “Statin treatment and new-onset diabetes: a review of proposed mechanisms”. 《Metabolism》 63 (6): 735–745. doi:10.1016/j.metabol.2014.02.014. PMID24641882.
Mancini GB, Baker S, Bergeron J, Fitchett D, Frohlich J, Genest J, 외. (2011). “Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference”. 《The Canadian Journal of Cardiology》 27 (5): 635–662. doi:10.1016/j.cjca.2011.05.007. PMID21963058.
Finegold JA, Manisty CH, Goldacre B, Barron AJ, Francis DP (April 2014). “What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice”. 《European Journal of Preventive Cardiology》 21 (4): 464–474. doi:10.1177/2047487314525531. PMID24623264. S2CID21064267.
pubmed.ncbi.nlm.nih.gov
Lehrer S, Rheinstein P. Statins combined with niacin reduce the risk of peripheral neuropathy. Int J Funct Nutr
. Sep-Oct 2020;1(1):3 PMID33330853
Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, 외. (December 2007). “Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths”. 《Lancet》 370 (9602): 1829–1839. doi:10.1016/S0140-6736(07)61778-4. PMID18061058. S2CID54293528.
Fulcher J, O'Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, 외. (April 2015). “Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials”. 《Lancet》 385 (9976): 1397–1405. doi:10.1016/s0140-6736(14)61368-4. hdl:2123/14127. PMID25579834. S2CID35330627.
Cangemi, Roberto; Romiti, Giulio Francesco; Campolongo, Giuseppe; Ruscio, Eleonora; Sciomer, Susanna; Gianfrilli, Daniele; Raparelli, Valeria (March 2017). “Gender related differences in treatment and response to statins in primary and secondary cardiovascular prevention: The never-ending debate”. 《Pharmacological Research》 117: 148–155. doi:10.1016/j.phrs.2016.12.027. PMID28012963. S2CID32861954.
Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, García FA, 외. (November 2016). “Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement”. 《JAMA》 316 (19): 1997–2007. doi:10.1001/jama.2016.15450. PMID27838723. S2CID205075217.
Lamaida N, Capuano E, Pinto L, Capuano E, Capuano R, Capuano V (September 2013). “The safety of statins in children”. 《Acta Paediatrica》 102 (9): 857–862. doi:10.1111/apa.12280. PMID23631461. S2CID22846175.
Liu YH, Liu Y, Duan CY, Tan N, Chen JY, Zhou YL, 외. (March 2015). “Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials”. 《Journal of Cardiovascular Pharmacology and Therapeutics》 20 (2): 181–192. doi:10.1177/1074248414549462. PMID25193735. S2CID28251228.
Finegold JA, Manisty CH, Goldacre B, Barron AJ, Francis DP (April 2014). “What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice”. 《European Journal of Preventive Cardiology》 21 (4): 464–474. doi:10.1177/2047487314525531. PMID24623264. S2CID21064267.
National Collaborating Centre for Primary Care (2010). 《NICE clinical guideline 67: Lipid modification》(PDF). London: National Institute for Health and Clinical Excellence. 38쪽. 10 October 2010에 원본 문서(PDF)에서 보존된 문서.
